Colistimethate Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-393

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Colistimethate (NDC 63323-393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (Colistimethate 309306)

Colistimethate for Injection, USP is a medication that comes in vials with 150 mg of Colistin base activity. It is used for intramuscular and intravenous administration and each vial is intended for a single use.*

FDA Label Image

Carton (Colistimethate 309306p)

Colistimethate for Injection is a medication used for intramuscular and intravenous therapy. Each vial contains 150mg of Colistin base activity. It is a prescription drug manufactured by Fresenius Kabi.*

FDA Label Image

Figure (Figure)

FDA Label Image

Logo (Fklz Address)

FDA Label Image

Micro (Microimge)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.